Vertebral Fracture Diagnosis in the Multinational BONE Study of Oral Ibandronate: Quality Management in Radiology

Journal of Clinical Densitometry

Volumn 11, Issue 2, 2008, Pages 221-231

  Armbrecht, Gabriele ^a   Blenk, Tilo ^a   Chesnut III, Charles H ^b   Gardner, Jill C ^b   von Ingersleben, Gabriele ^c   Mahoney, Paul ^d   Felsenberg, Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SYNARC INC   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Diagnosis; ibandronate; morphometric; postmenopausal osteoporosis; qualitative; vertebral fracture

Indexed keywords

IBANDRONIC ACID;

ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORPHOMETRICS; MULTICENTER STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; RADIODIAGNOSIS; VERTEBRA FRACTURE;

BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; SPINAL FRACTURES;

EID: 43049136269     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2007.10.002     Document Type: Article

References (25)

1. Division of Metabolic and Endocrine Drug Products, Food and Drug Administration, Rockville, Maryland. Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Available at: (1994). http://www.fda.gov/cder/guidance/osteo.pdf Accessed September 16, 2004
2. National Osteoporosis Foundation (NOF) Working Group on Vertebral Fractures Report. Assessing vertebral fractures. J Bone Miner Res 10 (1995) 18-23
3. Bauss F., and Russell R.G.G. Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing. Osteoporos Int 15 (2004) 423-433
4. Chesnut C.H., Skag A., Christiansen C., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19 (2004) 1241-1249
5. Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348 (1996) 1535-1541
6. Reginster J., Minne H.W., Sorensen O.H., et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11 (2000) 83-91
7. Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282 (1999) 1344-1352
8. Recker R.R., Stakkestad J.A., Chesnut C.H., et al. Insufficiently dosed i.v. ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis. Bone 34 (2004) 890-899
9. Yochum T.R., and Rowe L.J. Essentials of skeletal radiology. 2nd ed. Vol. 1 (1996), Williams & Wilkins, Baltimore, MD
10. Wu C., van Kuijk C., Li J., et al. Comparison of Digitized Images with the original radiography for semiquantitative assessment of osteoporotic fractures. Osteoporos Int 11 (2000) 25-30
11. Tan T.C.F., Sartoris D.J., and Resnick D. Differential diagnosis of osteoporotic vertebral fractures: pathology and radiology. In: Genant H.K., Jergas M., and van Kuijk C. (Eds). Vertebral Fracture in Osteoporosis (1995), Radiology Research and Education Foundation, San Francisco, CA 71-94
12. In: Daffner R.H. (Ed). Imaging of Vertebral Trauma. 2nd ed. (1996), Lippincott-Raven, Philadelphia, PA
13. Resnick D., Goergen T.G., and Niwayama G. Physical injury. In: Resnick D., and Niwayama G. (Eds). Diagnosis of Bone and Joint Disorders. 2nd ed. Vol. 5 (1988), Saunders Company, Philadelphia, PA 2756-3008
14. Garfin S.R., Gertzbein S., and Eismont F. Fractures of the lumbar spine: evaluation, classification, and treatment. In: Wiesel S.W., Weinstein J.N., Herkowitz H., Dvorak J., and Bell G. (Eds). The Lumbar Spine. 2nd ed. Vol. 2 (1996), Saunders Company, Philadelphia, PA
15. Dihlmann W. Gelenke - Wirbelverbindungen. 2nd ed. (1982), Georg Thieme, Stuttgart, Germany
16. Taylor J.A.M., and Resnick D. The aging spine: radiographic-pathologic correlation. In: Genant H.K., Jergas M., and van Kuijk C. (Eds). Vertebral Fracture in Osteoporosis (1995), Radiology Research and Education Foundation, San Francisco, CA 37-69
17. Resnick D., and Niwayama G. Intravertebral disk herniations: cartilaginous (Schmorl's) nodes. Radiology 126 (1978) 57-65
18. Resnick D. Osteochondroses. In: Resnick D., and Niwayama G. (Eds). Diagnosis of Bone and Joint Disorders. 2nd ed. Vol. 5 (1988), Saunders Company, Philadelphia, PA 3289-3334
19. Ziegler R., Scheidt-Nave C., and Leidig-Bruckner G. What is a vertebral fracture?. Bone 18 Suppl (1996) 169S-177S
20. Jergas M., and Felsenberg D. Assessment of vertebral fracture. In: Genant H.K., Guglielmi G., and Jergas M. (Eds). Bone Densitometry and Osteoporosis (1998), Springer Verlag, Berlin 227-267
21. Felsenberg D. Differentialdiagnose osteoporotischer wirbelkörperfrakturen. In: Ringe J.D., and Meunier P.J. (Eds). Senile Osteoporose (1996), Thieme Verlag, Stuttgart, Germany
22. Wu C.Y., Li J., Jergas M., et al. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporos Int 5 (1995) 354-370
23. Link T.M., Guglielmi G., van Kuijk C., et al. Radiologic assessment of osteoporotic vertebral fractures: diagnostic and prognostic implications. Eur Radiol 15 (2005) 1521-1532
24. Donner A., and Eliasziw M. A goodness of fit approach to inference procedures for the kappa statistic: confidence interval construction, significance testing and sample size estimation. Stat Med 11 (1992) 1511-1519
25. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed. (1981), John Wiley & Sons, New York p. 218